| RS2124450330 |
SLC2A1
|
Health Risk |
Pathogenic |
— |
| RS2124450420 |
SLC2A1
|
Health Risk |
Pathogenic |
GLUT1 deficiency syndrome 1, autosomal recessive |
| RS2124450429 |
SLC2A1
|
Health Risk |
Likely pathogenic |
— |
| RS2124450471 |
SLC2A1
|
Health Risk |
Pathogenic |
GLUT1 deficiency syndrome 1, autosomal recessive |
| RS2124450697 |
SLC2A1
|
Health Risk |
Pathogenic |
Encephalopathy due to GLUT1 deficiency, GLUT1 deficiency syndrome 1 |
| RS2124450705 |
SLC2A1
|
Health Risk |
Pathogenic |
Encephalopathy due to GLUT1 deficiency, Encephalopathy due to GLUT1 deficiency |
| RS2124450794 |
SLC2A1
|
Health Risk |
Likely pathogenic |
GLUT1 deficiency syndrome 1, autosomal recessive |
| RS2124450806 |
SLC2A1
|
Health Risk |
Pathogenic |
GLUT1 deficiency syndrome 1, autosomal recessive |
| RS2124450819 |
SLC2A1
|
Health Risk |
Likely pathogenic |
Encephalopathy due to GLUT1 deficiency, Encephalopathy due to GLUT1 deficiency |
| RS2124450830 |
SELENON
|
Health Risk |
Pathogenic |
Eichsfeld type congenital muscular dystrophy, Eichsfeld type congenital muscular dystrophy |
| RS2124450914 |
SLC2A1
|
Health Risk |
Pathogenic |
— |
| RS2124450939 |
SLC2A1
|
Health Risk |
Pathogenic |
GLUT1 deficiency syndrome 1, autosomal recessive |
| RS2124450950 |
SLC2A1
|
Health Risk |
Pathogenic |
Dystonia 9, Encephalopathy due to GLUT1 deficiency |
| RS2124452873 |
SELENON
|
Health Risk |
Pathogenic |
Eichsfeld type congenital muscular dystrophy, Eichsfeld type congenital muscular dystrophy |
| RS2124454648 |
SELENON
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital myopathy 4A, autosomal dominant |
| RS2124461790 |
SLC2A1
|
Health Risk |
Pathogenic |
— |
| RS2124461913 |
SLC2A1
|
Health Risk |
Pathogenic |
Dystonia 9, Dystonia 9 |
| RS2124461926 |
SLC2A1
|
Health Risk |
Pathogenic |
Dystonia 9, Dystonia 9 |
| RS2124470378 |
PPT1
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis 1, Neuronal ceroid lipofuscinosis 1 |
| RS2124472229 |
PPT1
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis 1, Neuronal ceroid lipofuscinosis 1 |
| RS2124472385 |
PPT1
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis 1, Neuronal ceroid lipofuscinosis 1 |
| RS2124474476 |
PPT1
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis 1, Neuronal ceroid lipofuscinosis 1 |
| RS2124474566 |
PPT1
|
Health Risk |
Likely pathogenic |
Neuronal ceroid lipofuscinosis 1, Neuronal ceroid lipofuscinosis 1 |
| RS2124478725 |
SLC2A1
|
Health Risk |
Pathogenic |
Dystonia 9, Encephalopathy due to GLUT1 deficiency |
| RS2124478772 |
TP73
|
Health Risk |
Pathogenic |
Ciliary dyskinesia, primary |
| RS2124478855 |
SLC2A1
|
Health Risk |
Pathogenic/Likely pathogenic |
GLUT1 deficiency syndrome 1, autosomal recessive |
| RS2124479949 |
GPC3
|
Health Risk |
Pathogenic |
Wilms tumor 1, Wilms tumor 1 |
| RS2124479966 |
GPC3
|
Health Risk |
Pathogenic |
Wilms tumor 1, Nonpapillary renal cell carcinoma |
| RS2124480362 |
GPC3
|
Health Risk |
Pathogenic |
Wilms tumor 1, Wilms tumor 1 |
| RS2124484378 |
PPT1
|
Health Risk |
Likely pathogenic |
Neuronal ceroid lipofuscinosis 1, Neuronal ceroid lipofuscinosis 1 |
| RS2124486090 |
SRY
|
Health Risk |
Likely pathogenic |
46, XX sex reversal 1 |
| RS2124486099 |
SRY
|
Health Risk |
Pathogenic |
SRY-related disorder, SRY-related disorder |
| RS2124486144 |
SRY
|
Health Risk |
Likely pathogenic |
SRY-related disorder, SRY-related disorder |
| RS2124486256 |
SRY
|
Health Risk |
Likely pathogenic |
46, XY sex reversal 1 |
| RS2124486291 |
SRY
|
Health Risk |
Likely pathogenic |
46, XY disorder of sex development |
| RS2124486390 |
SRY
|
Health Risk |
Pathogenic |
46, XY sex reversal 1 |
| RS2124487750 |
PPT1
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis 1, Neuronal ceroid lipofuscinosis 1 |
| RS2124487866 |
PPT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuronal ceroid lipofuscinosis 1, Neuronal ceroid lipofuscinosis 1 |
| RS2124487925 |
PPT1
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis 1, Neuronal ceroid lipofuscinosis 1 |
| RS2124487981 |
PPT1
|
Health Risk |
Likely pathogenic |
Neuronal ceroid lipofuscinosis 1, Neuronal ceroid lipofuscinosis 1 |
| RS2124489724 |
DHDDS
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa 59 |
| RS2124491843 |
ATP2B3
|
Health Risk |
Likely pathogenic |
X-linked progressive cerebellar ataxia, X-linked progressive cerebellar ataxia |
| RS2124494531 |
PPT1
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis 1, Neuronal ceroid lipofuscinosis 1 |
| RS2124501559 |
DHDDS
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 59, Retinitis pigmentosa 59 |
| RS2124508402 |
KDM1A
|
Health Risk |
Likely pathogenic |
— |
| RS2124510562 |
PUM1
|
Health Risk |
Likely pathogenic |
Neurodevelopmental delay, Neurodevelopmental delay |
| RS2124520154 |
SOS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Noonan syndrome and Noonan-related syndrome, RASopathy |
| RS2124521655 |
FMR1
|
Health Risk |
Likely pathogenic |
See cases, See cases |
| RS2124523419 |
KDM1A
|
Health Risk |
Likely pathogenic |
Neurodevelopmental delay, Palatal anomalies-widely spaced teeth-facial dysmorphism-developmental delay syndrome |
| RS2124524068 |
TP73
|
Health Risk |
Pathogenic |
Ciliary dyskinesia, primary |
| RS2124533497 |
TP73
|
Health Risk |
Pathogenic |
Ciliary dyskinesia, primary |
| RS2124537717 |
SOS1
|
Health Risk |
Conflicting classifications of pathogenicity |
RASopathy, RASopathy |
| RS2124538211 |
KDM1A
|
Health Risk |
Likely pathogenic |
— |
| RS2124544212 |
TP73
|
Health Risk |
Pathogenic |
Ciliary dyskinesia, primary |
| RS2124562542 |
SOS1
|
Health Risk |
Likely pathogenic |
Noonan syndrome 4, Noonan syndrome 4 |
| RS2124590812 |
MT-TF
|
Health Risk |
Likely pathogenic |
Hypokalemia, Hypomagnesemia |
| RS2124593402 |
ZMPSTE24
|
Health Risk |
Likely pathogenic |
— |
| RS2124596942 |
SOS1
|
Health Risk |
Likely pathogenic |
RASopathy, RASopathy |
| RS2124597984 |
TRIT1
|
Health Risk |
Pathogenic |
Combined oxidative phosphorylation deficiency 35, Combined oxidative phosphorylation deficiency 35 |
| RS2124612467 |
ELF4
|
Health Risk |
Pathogenic |
Autoinflammatory syndrome, familial |
| RS2124614205 |
ELF4
|
Health Risk |
Pathogenic |
Autoinflammatory syndrome, familial |
| RS2124614270 |
ELF4
|
Health Risk |
Pathogenic |
Autoinflammatory syndrome, familial |
| RS2124633546 |
LDLRAP1
|
Health Risk |
Pathogenic |
Hypercholesterolemia, familial |
| RS2124634791 |
GPC3
|
Health Risk |
Pathogenic/Likely pathogenic |
Simpson-Golabi-Behmel syndrome type 1, Wilms tumor 1 |
| RS2124644144 |
AIFM1
|
Health Risk |
Likely pathogenic |
Tip-toe gait, Tip-toe gait |
| RS2124647615 |
CEP104
|
Health Risk |
Pathogenic |
Intellectual developmental disorder, autosomal recessive 77 |
| RS2124648259 |
IDS
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-II |
| RS2124648266 |
IDS
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-II |
| RS2124648301 |
IDS
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucopolysaccharidosis, MPS-II |
| RS2124648304 |
IDS
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-II |
| RS2124648360 |
AIFM1
|
Health Risk |
Likely pathogenic |
— |
| RS2124648374 |
IDS
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-II |
| RS2124648387 |
AIFM1
|
Health Risk |
Likely pathogenic |
Auditory neuropathy, Auditory neuropathy |
| RS2124655627 |
GPC3
|
Health Risk |
Pathogenic |
Wilms tumor 1, Wilms tumor 1 |
| RS2124656989 |
AIFM1
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease X-linked recessive 4, Charcot-Marie-Tooth disease X-linked recessive 4 |
| RS2124656997 |
AIFM1
|
Health Risk |
Likely pathogenic |
Spondyloepimetaphyseal dysplasia, Bieganski type |
| RS2124663461 |
LDLRAP1
|
Health Risk |
Pathogenic |
Hypercholesterolemia, familial |
| RS2124667505 |
LDLRAP1
|
Health Risk |
Likely pathogenic |
— |
| RS2124688583 |
LDLRAP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypercholesterolemia, familial |
| RS2124690250 |
LDLRAP1
|
Health Risk |
Pathogenic |
Hypercholesterolemia, familial |
| RS2124740134 |
ARID1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, autosomal dominant 14 |
| RS2124740433 |
ARID1A
|
Health Risk |
Pathogenic |
— |
| RS2124740536 |
ARID1A
|
Health Risk |
Pathogenic |
ARID1A-related BAFopathy, Intellectual disability |
| RS2124740577 |
ARID1A
|
Health Risk |
Pathogenic |
Non-immune hydrops fetalis, Non-immune hydrops fetalis |
| RS2124742621 |
ARID1A
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 14 |
| RS2124743589 |
ARID1A
|
Health Risk |
Likely pathogenic |
— |
| RS2124782476 |
MFSD2A
|
Health Risk |
Pathogenic |
Microcephaly 15, primary |
| RS2124788629 |
ARID1A
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 14 |
| RS2124789091 |
ARID1A
|
Health Risk |
Pathogenic |
Malignant tumor of urinary bladder, Malignant tumor of urinary bladder |
| RS2124789497 |
ARID1A
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 14 |
| RS2124789902 |
ARID1A
|
Health Risk |
Pathogenic |
ARID1A-related BAFopathy, ARID1A-related BAFopathy |
| RS2124792233 |
ARID1A
|
Health Risk |
Pathogenic |
Malignant tumor of urinary bladder, Malignant tumor of urinary bladder |
| RS2124792461 |
ARID1A
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 14 |
| RS2124792810 |
ARID1A
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 14 |
| RS2124822282 |
SUMF1
|
Health Risk |
Pathogenic |
Multiple sulfatase deficiency, Multiple sulfatase deficiency |
| RS2124822828 |
SUMF1
|
Health Risk |
Likely pathogenic |
Multiple sulfatase deficiency, Multiple sulfatase deficiency |
| RS2124823079 |
SUMF1
|
Health Risk |
Pathogenic |
Multiple sulfatase deficiency, Multiple sulfatase deficiency |
| RS2124823466 |
SUMF1
|
Health Risk |
Pathogenic |
Multiple sulfatase deficiency, Multiple sulfatase deficiency |
| RS2124844270 |
ATP2B2
|
Health Risk |
Pathogenic |
Hearing loss, autosomal dominant 82 |
| RS2124849065 |
IDH1
|
Health Risk |
Likely pathogenic |
Paroxysmal extreme pain disorder, Paroxysmal extreme pain disorder |